(Q47739578)

5 February 2018

review article

1 reference

title

The atherogenic lipoprotein phenotype and vascular endothelial dysfunction (English)

1 reference

5 February 2018

1 reference

1 reference

1

1 reference

5 February 2018

author name string

Petrie JR

series ordinal

2

1 reference

5 February 2018

Jaap AJ

series ordinal

3

1 reference

5 February 2018

publication date

1 June 1998

1 reference

5 February 2018

published in

Atherosclerosis

1 reference

5 February 2018

volume

138

1 reference

5 February 2018

issue

2

1 reference

5 February 2018

page(s)

229-235

1 reference

5 February 2018

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Beyond LDL cholesterol reduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Relations Between Plasma Lipids and Postheparin Plasma Lipases and VLDL and LDL Subfraction Patterns in Normolipemic Men and Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Endothelial vasodilator dysfunction: pathogenetic link to myocardial ischaemia or epiphenomenon?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Control of shear stress in the epicardial coronary arteries of humans: impairment by atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Close relation of endothelial function in the human coronary and peripheral circulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol-fed rabbits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Antioxidants and atherosclerotic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Inactivation of endothelial derived relaxing factor by oxidized lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Low superoxide scavenging activity associated with enhanced superoxide generation by monocytes from male hypertriglyceridemia with and without diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

The effect of dietary treatment on lipid peroxidation and antioxidant status in newly diagnosed noninsulin dependent diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Coronary atherosclerotic wall thickening and vascular reactivity in humans. Elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Effects of high-density lipoprotein on acetylcholine-induced coronary vasoreactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Sex differences in endothelial function in normal and hypercholesterolaemic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Low-density lipoprotein size, high-density lipoprotein concentration, and endothelial dysfunction in non-insulin-dependent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Binding of transition metals by apolipoprotein A-I-containing plasma lipoproteins: inhibition of oxidation of low density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Lipolyzed hypertriglyceridemic serum and triglyceride-rich lipoprotein cause lipid accumulation in and are cytotoxic to cultured human endothelial cells. High density lipoproteins inhibit this cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Disruption of endothelial barrier function by lipolytic remnants of triglyceride-rich lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Molecular size as a determinant of fractional loss from the intima-inner media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Diabetic postprandial triglyceride-rich lipoproteins increase esterified cholesterol accumulation in THP-1 macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Effect of a single high-fat meal on endothelial function in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Hypertriglyceridaemia and hypercoagulability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Hemostatic function and coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

7 January 2021

Atheroma: more than mush

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Levels of soluble cell adhesion molecules in patients with dyslipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Oxidative susceptibility of low density lipoprotein subfractions is related to their ubiquinol-10 and alpha-tocopherol content

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Distribution of PAF-acetylhydrolase activity in human plasma low-density lipoprotein subfractions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Are increased plasma non-esterified fatty acid concentrations a risk marker for coronary heart disease and other chronic diseases?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Exposure to fatty acid increases human low density lipoprotein transfer across cultured endothelial monolayers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Sera containing elevated nonesterified fatty acids from patients with angiographically documented coronary atherosclerosis cause marked lipid accumulation in cultured human arterial smooth muscle-derived cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Purification and identification of very low density lipoprotein toxicity preventing activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Effects of free fatty acids found increased in women who develop pre-eclampsia on the ability of endothelial cells to produce prostacyclin, cGMP and inhibit platelet aggregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Fatty acid-mediated effects on the glutathione redox cycle in cultured endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Does free fatty acid infusion impair insulin action also through an increase in oxidative stress?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Oleic Acid Inhibits Endothelial Nitric Oxide Synthase by a Protein Kinase C–Independent Mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

Small, dense low density lipoproteins, the insulin resistance syndrome and noninsulin-dependent diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

7 January 2021

Postprandial state and atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

7 January 2021

Dyslipidemia in peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

7 January 2021

Change in LDL particle size is associated with change in plasma triglyceride concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900037-9

7 January 2021

10.1016/S0021-9150(98)00037-9

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018